Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells
Yichun Zheng(Zhejiang International Studies University), Hiroshi Miyamoto(Tokushima University)
Cited by 103
Related Papers
Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
|Oncotarget|2016|71
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial Pneumonia
|Oncotarget|2013|42
Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression
|British Journal of Cancer|2017|42
ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
|Endocrine Connections|2018|33
Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
|International Journal of Molecular Sciences|2021|21